Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate-specific membrane antigen.
Fair WR, Israeli RS, Heston WD. Fair WR, et al. Among authors: heston wd. Prostate. 1997 Jul 1;32(2):140-8. doi: 10.1002/(sici)1097-0045(19970701)32:2<140::aid-pros9>3.0.co;2-q. Prostate. 1997. PMID: 9215402 Review.
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.
Chang SS, Reuter VE, Heston WD, Gaudin PB. Chang SS, et al. Among authors: heston wd. Urology. 2001 Apr;57(4):801-5. doi: 10.1016/s0090-4295(00)01094-3. Urology. 2001. PMID: 11306418
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
Israeli RS, Miller WH Jr, Su SL, Samadi DS, Powell CT, Heston WD, Wise GJ, Fair WR. Israeli RS, et al. Among authors: heston wd. J Urol. 1995 Mar;153(3 Pt 1):573-7. doi: 10.1016/s0022-5347(01)67651-1. J Urol. 1995. PMID: 7532229 Clinical Trial.
In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Uchida A, O'Keefe DS, Bacich DJ, Molloy PL, Heston WD. Uchida A, et al. Among authors: heston wd. Urology. 2001 Aug;58(2 Suppl 1):132-9. doi: 10.1016/s0090-4295(01)01256-0. Urology. 2001. PMID: 11502468
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Gregor PD, Wolchok JD, Ferrone CR, Buchinshky H, Guevara-PatiƱo JA, Perales MA, Mortazavi F, Bacich D, Heston W, Latouche JB, Sadelain M, Allison JP, Scher HI, Houghton AN. Gregor PD, et al. Vaccine. 2004 Apr 16;22(13-14):1700-8. doi: 10.1016/j.vaccine.2003.10.048. Vaccine. 2004. PMID: 15068853
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E. Connor J, et al. J Exp Med. 1993 Apr 1;177(4):1127-34. doi: 10.1084/jem.177.4.1127. J Exp Med. 1993. PMID: 8459207 Free PMC article.
Cancer of the prostate: a nutritional disease?
Fair WR, Fleshner NE, Heston W. Fair WR, et al. Urology. 1997 Dec;50(6):840-8. doi: 10.1016/S0090-4295(97)00339-7. Urology. 1997. PMID: 9426711 Review.
Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.
Saito S, Tazaki H, Heston WD, Fair WR. Saito S, et al. Among authors: heston wd. Int J Urol. 1996 Jan;3(1 Suppl):S35-9. doi: 10.1111/j.1442-2042.1996.tb00080.x. Int J Urol. 1996. PMID: 24304018
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y. Cozzi PJ, et al. Among authors: heston wd. FASEB J. 2001 May;15(7):1306-8. doi: 10.1096/fj.00-0533fje. FASEB J. 2001. PMID: 11344122 No abstract available.
Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD. Horiguchi Y, et al. Among authors: heston wd. Gene Ther. 2000 May;7(10):844-51. doi: 10.1038/sj.gt.3301157. Gene Ther. 2000. PMID: 10845722
155 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback